Akari Therapeutics vs ALNYLAM PHARMACEUTICALS
On overall TruNorth grade, Akari Therapeutics scores higher (Akari Therapeutics: B, ALNYLAM PHARMACEUTICALS: C). Both graded from public records across nine values categories.
Political donations
FEC: $313K in executive political donations; partisan lean split across 11 executive donors.
FEC: $52K PAC donations; 62% to Republican, 38% to Democratic committees.
Environment
No public record found.
No public record found.
Labor
No public record found.
2 federal penalties totaling $202K since 2000 (Violation Tracker).
DEI
No public record found.
EEO-1 workforce demographics on federal record (FY2020, DOL OFCCP FOIA release): 1,138 US employees — 49% women, 31.9% racial/ethnic minorities; management 47.9% women, 27.2% minorities.
Charity
No public record found.
No public record found.
Animal testing
No public record found.
No public record found.
Firearms
No public record found.
No public record found.
Privacy
No public record found.
No public record found.
Executive pay
CEO total compensation $2K — SEC proxy statement (DEF 14A, 2025). No CEO-to-worker pay ratio disclosed in a parseable form.
CEO-to-median-worker pay ratio 48:1 (median employee pay $312,180; CEO total compensation $25K) — SEC proxy statement (DEF 14A, 2025).
Compare any two brands on the values you care about — personalized to your 30-second quiz.
Open TruNorth →